The latest update is out from Anagenics Limited ( (AU:AN1) ).
Anagenics Limited has announced that its shareholders have approved the issuance of 35,000,000 shares to FOS Capital Limited at a price of 1 cent per share. This decision, passed by the requisite majority at the recent General Meeting, signifies a strategic move for Anagenics, potentially impacting its financial operations and market positioning. FOS Capital, a manufacturer and distributor of lighting solutions, aims to expand its market share through strategic acquisitions, aligning with its growth objectives.
More about Anagenics Limited
Anagenics Limited operates in the beauty, health, and wellness industry, focusing on the global distribution and sales of proprietary and licensed brands of anti-aging solutions. Its subsidiary, BLC Cosmetics Pty Ltd, specializes in the sales and distribution of both Australian and international cosmetic and wellness products.
Current Market Cap: A$3.69M
See more insights into AN1 stock on TipRanks’ Stock Analysis page.